Taiwan Liposome Company Ltd - ADR
TLC
Get informed when a big investor buys or sells
+ FollowMarket Cap$294.54M
Close$
$40.99
485.5% upside
Current Fair Value
485.5% upsideUndervalued by 485.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $294.54 Million |
|---|---|
| Enterprise Value | $294.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-24.89 |
| Beta | 0.8 |
| Outstanding Shares | 42,077,467 |
Return
| Return on Equity | -532.12% |
|---|---|
| Return on Assets | -60.34% |
| Return on Invested Capital | -80.90% |
Valuation & Multiples
| P/E Ratio | -8.98 |
|---|---|
| PEG | 13.04 |
| Price to Sales | 1.17 |
| Price to Book Ratio | 0.54 |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | - |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Taiwan Liposome Company Ltd
CEO: Jilong Hong